Ticker Details
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
IPO Date:	May 11, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.53B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.27 | 2.99%
Avg Daily Range (30 D):	$0.58 | 4.67%
Avg Daily Range (90 D):	$0.42 | 3.88%

Institutional Daily Volume
Avg Daily Volume:	.93M
Avg Daily Volume (30 D):	3.25M
Avg Daily Volume (90 D):	2.28M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	94
Avg Trade Size (Sh.) (90 D):	86

Institutional Trades
Total Institutional Trades:	5,792
Avg Institutional Trade:	$3.05M
Avg Institutional Trade (30 D):	$3.2M
Avg Institutional Trade (90 D):	$2.75M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.87M
Avg Closing Trade (30 D):	$6.77M
Avg Closing Trade (90 D):	$4.3M
Avg Closing Volume:	134.25K

News

Mar 23, 2026 @ 5:17 PM Biohaven Stock Down 70% but One Fund's New $6 Mill... Source: Jonathan Ponciano

Jan 15, 2026 @ 2:48 AM Biohaven (BHVN) Stock Is Trending Overnight â€â... Source: Mohd Haider

Dec 26, 2025 @ 2:26 PM Stock Market Today: Dow Jones, S&P 500, Nasdaq Fut... Source: Rishabh Mishra

Dec 2, 2025 @ 6:00 PM Migraine Clinical Trial Pipeline Expands as 30+ Co... Source: Delveinsight

Nov 19, 2025 @ 10:15 PM Biohaven's Chief Accounting Officer Scooped Up 17,... Source: Robert Izquierdo

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.88	$-1.12	$-6.86
Diluted EPS	$-.88	$-1.12	$-6.86
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-130.53M	$-145.56M	$-738.82M
Operating Income / Loss	$-130.43M	$-142.73M	$-745.38M
Cost of Revenue
Net Cash Flow	$44.33M	$44.4M	$130.24M
PE Ratio